View all news

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance

08/07/2018


Acquires WellSpring Pharma Services for $18 Million in Cash to
Expand Contract Manufacturing Business and Accelerate ANDA
Pipeline Re-commercialization Efforts



Targets sNDA Filing for Cortrophin Gel by Q1 2020


Records Initial Royalties on Commercial Sales of Yescarta®
maceuticals Q2 2018 Earnings Release Tables

Multimedia Files:

View all news